[ad_1]
October 10, 2022
Damage or disease in one of our most complex organs—the human brain—can be difficult to diagnose and difficult to treat. Advancing technologies for mental health requires multidisciplinary collaboration from clinicians and engineers in fields ranging from data science to medicine.
University of Washington annual this fall Engineering education series Research shows the potential to transform psychiatry from infancy to late adulthood. Two UW engineers talk about their work — diagnosing and treating Alzheimer’s disease and developing brain treatments for children. These talks are free and open to the public, and this year they will be both live and live. Registration is required.
From Discovery to Design: Early Detection and Treatment of Alzheimer’s Disease
Valerie Daggett
The series begins on October 13, at 7:30 pm in Khan Hall 130. Valerie DaggettProfessor of Bioengineering. Since the 1990s, Daggett has been studying the misfolded proteins that drive diseases such as Alzheimer’s and Parkinson’s. More than 5 million Americans are living with Alzheimer’s disease — a number that will grow to 14 million by 2050 — and there is currently no cure. Daggett’s research uses computational and experimental methods to design diagnostic and therapeutic agents to target these diseases. This work is ready to be established Organization A promising platform for early diagnosis and treatment of Alzheimer’s. Hear from Daggett about the technology and collaborations driving this research.
Brain engineering treatments for children
Elizabeth Nance
Oct. 26, 7:30 p.m. in Kane Hall 130; Elizabeth Nance, associate professor of chemical engineering and bioengineering, will talk about developing brain disease treatments for newborns and children with the goal of improving neurological function and quality of life. Children make up 27% of the world’s population, but most treatments for mental illness are tested on adults. Pediatric clinical trials often follow years later. This has created a huge gap in medical technology for babies and children. Nance’s research focuses on understanding the brain’s response to injury or disease and developing nanotherapeutic platforms to treat brain disease using nanotechnology, neurobiology, and data science tools.
Elizabeth Nance (background) and Hugo Pontes (front), who worked with Nance as a UW undergraduate studying chemical engineering, examine thin sections of brain tissue under a microscope. Nance and Pontes looked at how certain cells responded to drug nanoparticle treatment to see if the treatment could reduce brain damage.Brian Nakata
account(s) College of Engineering • Department of Bioengineering • Department of Chemical Engineering • Elizabeth Nance • Valerie Daggett
[ad_2]
Source link
